Clinical Trial Update: Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating how ketoconazole affects romidepsin pharmacokinetics in patients with hematologic malignancy and malignant lymphoma; results posted aft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Malignant Lymphoma

Drugs mentioned

• Ketoconazole (Ketoconazole)
• Romidepsin (romidepsin)

Snippet

Sponsor: Celgene | Conditions: Hematologic Malignancy, Malignant Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2013-05-15